Literature DB >> 16368892

Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.

Michal Dagan-Berger1, Rotem Feniger-Barish, Shani Avniel, Hanna Wald, Eithan Galun, Valentin Grabovsky, Ronen Alon, Arnon Nagler, Adit Ben-Baruch, Amnon Peled.   

Abstract

The chemokine receptor CXCR3 is predominantly expressed on activated T and natural killer (NK) cells. CXCR3 and its ligands, CXCL11, CXCL10, and CXCL9, play a major role in T-helper 1 (Th1)-dependent inflammatory responses. CXCL11 is the most dominant physiological inducer of adhesion, migration, and internalization of CXCR3. To study the role of CXCR3 carboxyl-terminus and the third intracellular (3i) loop in chemokine-mediated migration, adhesion, and CXCR3 internalization, we generated CXCR3 receptors mutated in their distal (Ser-Thr domain) or proximal (trileucine domain) membrane carboxyl terminus, and/or the third intracellular loop. We found that migration of CXCR3-expressing HEK 293 cells toward CXCL11 was pertussis toxin-dependent and required the membrane proximal carboxyl terminus of CXCR3. Internalization induced by CXCL11 and protein kinase C (PKC) activation was also regulated by the membrane proximal carboxyl terminus; however, only CXCL11-induced internalization required the LLL motif of this region. Internalization and Ca(2+) flux induced by CXCL11 were independent of the 3i loop S245, whereas migration at high CXCL11 concentrations, integrin-dependent adhesion, and actin polymerization were S245 dependent. Our findings indicate that CXCL11-dependent CXCR3 internalization and cell migration are regulated by the CXCR3 membrane proximal carboxyl terminus, whereas adhesion is regulated by the 3i loop S245. Thus, distinct conformational changes induced by a given CXCR3 ligand trigger different downstream effectors of adhesion, motility, and CXCR3 desensitization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368892     DOI: 10.1182/blood-2004-01-0214

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

Review 1.  CXCR3 in carcinoma progression.

Authors:  Bo Ma; Ahmad Khazali; Alan Wells
Journal:  Histol Histopathol       Date:  2015-02-09       Impact factor: 2.303

2.  Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.

Authors:  D J Scholten; M Canals; M Wijtmans; S de Munnik; P Nguyen; D Verzijl; I J P de Esch; H F Vischer; M J Smit; R Leurs
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock.

Authors:  Daniela S Herzig; Brandon R Driver; Geping Fang; Tracy E Toliver-Kinsky; Eric N Shute; Edward R Sherwood
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

4.  Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection.

Authors:  Todd R Wuest; Daniel J J Carr
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

5.  Silencing of WWP2 inhibits adhesion, invasion, and migration in liver cancer cells.

Authors:  Yong Qin; Sheng-Qian Xu; De-Biao Pan; Guan-Xiong Ye; Cheng-Jun Wu; Shi Wang; Chao-Jun Wang; Jin-Yan Jiang; Jing Fu
Journal:  Tumour Biol       Date:  2015-12-10

Review 6.  Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis.

Authors:  Alan Wells; Yvonne L Chao; Jelena Grahovac; Qian Wu; Douglas A Lauffenburger
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

7.  Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.

Authors:  Qian Wu; Rajiv Dhir; Alan Wells
Journal:  Mol Cancer       Date:  2012-01-11       Impact factor: 27.401

8.  Therapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis.

Authors:  Daniela S Herzig; Yin Guo; Geping Fang; Tracy E Toliver-Kinsky; Edward R Sherwood
Journal:  Crit Care       Date:  2012-09-19       Impact factor: 9.097

9.  Interaction between CXCR4 and CCL20 pathways regulates tumor growth.

Authors:  Katia Beider; Michal Abraham; Michal Begin; Hanna Wald; Ido D Weiss; Ori Wald; Eli Pikarsky; Rinat Abramovitch; Evelyne Zeira; Eithan Galun; Arnon Nagler; Amnon Peled
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

10.  The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor.

Authors:  Andrea Meiser; Anja Mueller; Emma L Wise; Ellen M McDonagh; Sarah J Petit; Namita Saran; Peter C Clark; Timothy J Williams; James E Pease
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.